or Try an Advanced Search...

    Technical Analysis for MSB - Mesoblast limited  

    Grade Last Price % Change Price Change
    A 0.930 1.64% 0.015
    MSB closed up 1.64 percent on Friday, April 26, 2024, on 73 percent of normal volume.
    3 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Up Up Up
    Historical MSB trend table...
    Date Alert Name Type % Chg
    Doji - Bearish? Reversal 0.00%
    Wide Bands Range Expansion 0.00%
    Wide Bands Range Expansion 1.64%
    Gapped Up Strength 1.64%
    Narrow Range Bar Range Contraction 16.98%
    Inside Day Range Contraction 16.98%
    Wide Bands Range Expansion 16.98%
    Golden Cross Bullish 16.98%
    Narrow Range Bar Range Contraction 16.98%
    Wide Bands Range Expansion 16.98%
    Older End-of-Day Signals for MSB ...

       Recent Intraday Alerts

    Alert Time
    Up 3% about 20 hours ago
    Rose Above Previous Day's High about 20 hours ago
    Up 2% about 21 hours ago
    Down 2% about 23 hours ago
    Down 1% about 23 hours ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    MSB Chart by TradingView
    Basic chart:

    Profile

    Mesoblast Limited is engaged in developing cell-based medicines. The Company has leveraged its technology platform, which is based on specialized cells known as mesenchymal lineage adult stem cells, to establish a portfolio of late-stage product candidates. Its allogeneic, off-the-shelf cell product candidates target advanced stages of diseases with high, unmet medical needs, including cardiovascular conditions, orthopedic disorders, immunologic and inflammatory disorders and oncologic/hematologic conditions.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Medicine Biotechnology Disease Diseases Life Sciences Biology Disorders Stem Cell Stem Cells Cell Biology Induced Stem Cells Adult Stem Cell

    Is MSB a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Apr 26 Three Leading Growth Companies In Australia With Insider Ownership Reaching 27%
    Mar 27 Mesoblast (MESO) to File Pediatric GVHD Drug BLA, Stock Up
    Mar 26 After Almost 4 Years, FDA Says Mesoblast Phase 3 Therapy Data Can Support Resubmission For Serious Complications in Children Following Stem Cell Transplant
    Mar 26 United States Food & Drug Administration (FDA) Notifies Mesoblast that Available Clinical Data from Phase 3 Trial Appear Sufficient to Support BLA Submission for Remestemcel-L in Children with Steroid-Refractory Acute Graft Versus Host Disease (SR-aGVHD)
    Mar 13 Mesoblast Successfully Completes Placement and Accelerated Entitlement Offer
    Mar 10 United States Food & Drug Administration (FDA) Supports Accelerated Approval Pathway for Rexlemestrocel-L in End-Stage Heart Failure Patients with a Left Ventricular Assist Device (LVAD)
    Mar 3 Mesoblast Limited (NASDAQ:MESO) Q2 2024 Earnings Call Transcript
    Feb 29 Mesoblast First Half 2024 Earnings: EPS Beats Expectations, Revenues Lag
    Feb 28 Mesoblast Reports Financial Results and Operational Update for Half-Year Ended December 31, 2023
    Feb 26 Mesoblast Financial Results and Corporate Update Webcast
    See more MSB news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 1.425
    52 Week Low 0.255
    Average Volume 11,670,094
    200-Day Moving Average 0.477
    50-Day Moving Average 0.521
    20-Day Moving Average 0.820
    10-Day Moving Average 0.816
    Average True Range 0.061
    RSI (14) 72.14
    ADX 49.72
    +DI 46.646
    -DI 15.639
    Chandelier Exit (Long, 3 ATRs) 0.793
    Chandelier Exit (Short, 3 ATRs) 0.507
    Upper Bollinger Bands 1.052
    Lower Bollinger Band 0.587
    Percent B (%b) 0.74
    BandWidth 56.697
    MACD Line 0.097
    MACD Signal Line 0.106
    MACD Histogram -0.0085
    Fundamentals Value
    Market Cap 546.46 Million
    Num Shares 588 Million
    EPS -0.18
    Price-to-Earnings (P/E) Ratio -5.11
    Price-to-Sales 109.07
    Price-to-Book 3.26
    PEG Ratio 0.00
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 1.020
    Resistance 3 (R3) 1.017 0.983 1.005
    Resistance 2 (R2) 0.983 0.960 0.985 1.000
    Resistance 1 (R1) 0.957 0.946 0.970 0.960 0.995
    Pivot Point 0.923 0.923 0.930 0.925 0.923
    Support 1 (S1) 0.897 0.900 0.910 0.900 0.865
    Support 2 (S2) 0.863 0.886 0.865 0.860
    Support 3 (S3) 0.837 0.863 0.855
    Support 4 (S4) 0.840